Skip to main content Accessibility help
×
Hostname: page-component-848d4c4894-nmvwc Total loading time: 0 Render date: 2024-07-01T00:50:05.913Z Has data issue: false hasContentIssue false

18 - Role of endothelial cells in transplant rejection

Published online by Cambridge University Press:  07 September 2009

Marlene L. Rose
Affiliation:
Division of Cardiothoracic Surgery, Imperial College School of Medicine, Harefield, Middlesex
Beverley J. Hunt
Affiliation:
University of London
Lucilla Poston
Affiliation:
University of London
Michael Schachter
Affiliation:
Imperial College of Science, Technology and Medicine, London
Alison W. Halliday
Affiliation:
St George's Hospital, London
Get access

Summary

Introduction

Approximately 36 000 transplants are performed throughout the world each year, of which the majority are kidney transplants. About 5000 hearts, 6500 livers and 1200 lung transplants are performed. Rejection remains the most common complication following transplantation and is the major cause of morbidity and mortality. Endothelial cells form the interface between donor tissue and recipient blood and so are the first donor cells to be recognized by the host's immune system. This fact, and the observation that they express numerous molecules able to stimulate lymphocytes, has led to much research into their precise role in transplant rejection. It is our view that endothelial cells are pivotal both in controlling the egress of inflammatory cells into the allografted organ and also as specific antigen-presenting cells (APCs), by presenting foreign molecules to the immune system (Figure 18.1).

Rejection is mediated by both cell-mediated and humoral mechanisms but the relative importance of these pathways differs in acute and chronic rejection. This chapter briefly describes the features of acute and chronic rejection and then outlines the role of endothelial cells in this process.

Basic mechanism of rejection

The major stimulus for rejection of allografted organs is recognition that the donor cells are foreign, by recognition of antigens that are coded by the major histocompatibility complex (MHC). There are two classes of MHC: class I (human leukocyte antigen, HLA) ABC) and class II (HLA-DR, DP, DQ).

Type
Chapter
Information
An Introduction to Vascular Biology
From Basic Science to Clinical Practice
, pp. 381 - 397
Publisher: Cambridge University Press
Print publication year: 2002

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×